What is the Optimal Timing to Assess the Effect of 5-ASA in Patients with Mild-to- Moderate Ulcerative Colitis? A Single-Center Prospective Observational Study
<title>Abstract</title> Background First-line therapy for mild-to-moderate ulcerative colitis is 5-aminosalicylic acid. Optimal timing for the first evaluation after initiation ...